<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03273023</url>
  </required_header>
  <id_info>
    <org_study_id>S2384</org_study_id>
    <nct_id>NCT03273023</nct_id>
  </id_info>
  <brief_title>PROMUS PREMIERâ„¢ China Post-Approval Study</brief_title>
  <official_title>PROMUS PREMIER China Registry Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compile real-world clinical outcome data for the Promus PREMIERTM Everolimus-Eluting
      Platinum Chromium Coronary Stent System (Promus PREMIERTM Stent System) in routine clinical
      practice in China.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 31, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>12-month Primary Endpoint: Major Adverse Cardiac Event (MACE) rate, defined as cardiac death, myocardial infarction (MI) and target vessel revascularization (TVR)</measure>
    <time_frame>12-month follow up</time_frame>
    <description>The primary endpoint is the 12-month major adverse cardiac event (MACE) rate, defined as cardiac death, myocardial infarction (MI) and target vessel revascularization (TVR)</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>To Observe Clinical Outcomes in Subjects Receiving the Promus PREMIERTM Stent System</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System</intervention_name>
    <description>Promus PREMIERTM Stent System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects who are candidates for coronary artery stenting, signed the informed consent
        form and eligible to receive a Promus PREMIERTM Stent System will be evaluated for
        enrollment in this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be at least 18 years of age

          -  Subject understands and provides written informed consent

          -  Subject who is clinically indicated and will have an attempt of at least one Promus
             PREMIERTM Stent OR Subject who is clinically indicated and was implanted with at least
             one Promus PREMIERTM Stent

          -  Subject is willing to comply with all protocol-required follow-up evaluation

        Exclusion Criteria:

          -  Exclusion criteria are not required in the PE PREMIERTM China Post-Approval Study
             which is an &quot;all comers&quot; study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>YUWEI ZHANG</last_name>
    <phone>010-85216440</phone>
    <email>Yuwei.Zhang@bsci.com</email>
  </overall_contact>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2017</study_first_submitted>
  <study_first_submitted_qc>September 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2017</study_first_posted>
  <last_update_submitted>September 5, 2017</last_update_submitted>
  <last_update_submitted_qc>September 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Everolimus</mesh_term>
    <mesh_term>Chromium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

